Traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses

A new type of coronavirus technology, applied in the direction of antiviral agents, pharmaceutical formulations, drug combinations, etc., can solve the problems of no standardized treatment, no targeted treatment, no standardized treatment, etc., to reduce lung tissue exudate, relieve Lung damage, effect of reducing pulmonary edema state

Inactive Publication Date: 2020-09-18
王相钧
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] The new coronavirus enters human cells by recognizing the ACE2 protein. ACE2 is the key molecule of the human "renin-angiotensin-aldosterone system (RAS)" and the "door handle" for the "new coronavirus" to invade the human body. It thus opens the door to enter cells. Western medicine currently has no solution for COVID-19. The existing Chinese medicine treatment has no standardized treatment, no standardized treatment, no classified treatment suitable for most people, and no special effects at present. There is no traditional Chinese medicine treatment for targeted treatment in the existing technology; in view of these defects, it is necessary to design a traditional Chinese medicine agent for the treatment of pneumonia caused by new coronavirus infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses
  • Traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] A traditional Chinese medicinal preparation for treating pneumonia caused by a new type of coronavirus. The formula includes: Poria cocos, Poria, Alisma, talc, Coptis chinensis, Moutan cortex, almonds, donkey-hide gelatin, and licorice. The mass percentages of each component are: 10 parts of pig Ling, 20 parts of Poria, 15 parts of Alisma, 10 parts of talc, 15 parts of Coptis chinensis, 15 parts of Moutan bark, 15 parts of almonds, 10 parts of donkey-hide gelatin, and 15 parts of licorice.

[0031] Among them, the sundries such as the sand and soil are removed after the Polyporus plucked; when the Coptis chinensis is picked, the fibrous roots are cut off at the base, and the leaves are cut off when the buds are trimmed; dry.

[0032] The preparation process of the traditional Chinese medicine medicament for the treatment of pneumonia caused by novel coronavirus, step 1, raw material selection; step 2, raw material processing; step 3, medicament pre-production; step 4, m...

Embodiment 2

[0048] A traditional Chinese medicinal agent for treating pneumonia caused by a new type of coronavirus. The formula includes: Polyporus cocos, Poria cocos, Alisma, talc, Coptis chinensis, Moutan cortex, almonds, donkey-hide gelatin and licorice. The mass percentages of each component are: 15 parts of pig Ling, 15 parts of Poria, 15 parts of Alisma, 15 parts of talc, 15 parts of Coptis chinensis, 15 parts of Moutan bark, 15 parts of almond, 10 parts of donkey-hide gelatin, and 15 parts of licorice.

[0049] Among them, the sundries such as the sand and soil are removed after the Polyporus plucked; when the Coptis chinensis is picked, the fibrous roots are cut off at the base, and the leaves are cut off when the buds are trimmed; dry.

[0050] The preparation process of the traditional Chinese medicine medicament for the treatment of pneumonia caused by novel coronavirus, step 1, raw material selection; step 2, raw material processing; step 3, medicament pre-production; step 4,...

Embodiment 3

[0066] A traditional Chinese medicinal preparation for treating pneumonia caused by a new type of coronavirus. The formula includes: Poria cocos, Poria, Alisma, talc, Coptis chinensis, Moutan cortex, almonds, donkey-hide gelatin, and licorice. The mass percentages of each component are: 20 parts of pig Ling, 15 parts of Poria, 10 parts of Alisma, 15 parts of talc, 15 parts of Coptis chinensis, 15 parts of Moutan bark, 15 parts of almonds, 10 parts of donkey-hide gelatin, and 15 parts of licorice.

[0067] Among them, the sundries such as the sand and soil are removed after the Polyporus plucked; when the Coptis chinensis is picked, the fibrous roots are cut off at the base, and the leaves are cut off when the buds are trimmed; dry.

[0068] The preparation process of the traditional Chinese medicine medicament for the treatment of pneumonia caused by novel coronavirus, step 1, raw material selection; step 2, raw material processing; step 3, medicament pre-production; step 4, m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses. The preparation adopting the formula comprises the components in parts by mass of 15-25 parts of polyporus umbellatus, 15-60 parts of poria cocos, 15-25 parts of rhizoma alismatis, 10-20 parts of talc, 10-20 parts of rhizoma coptidis, 15-25 parts of tree peony bark, 6-30 parts of apricot kernels, 10-20 parts of colla corii asini and 15-25 parts of licorice roots. The traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses can realize target effects on human cell surface ACE2 receptors, and can block a way that the novel coronaviruses invade organisms, so that the traditional Chinese medicine preparation has the effects of preventing and treating clinical situation of the novel coronaviruses. The traditional Chinese medicine preparation for treating pneumonia infected with novel coronaviruses has obvious and quick improvement effects on symptoms of fever, dry cough, weakness, chest pain and the like, can reduce blood pressure, alleviate oedematous and has special effects on patients suffering from albuminuria and renalfunction damage through laboratory examination.

Description

technical field [0001] The present invention relates to the technical field of traditional Chinese medicine medicaments, in particular to traditional Chinese medicine medicaments for the treatment of novel coronavirus-infected pneumonia. Background technique [0002] The new coronavirus enters human cells by recognizing the ACE2 protein. ACE2 is the key molecule of the human "renin-angiotensin-aldosterone system (RAS)" and the "door handle" for the "new coronavirus" to invade the human body. It thus opens the door to enter cells. Western medicine currently has no solution for COVID-19. The existing Chinese medicine treatment has no standardized treatment, no standardized treatment, no classified treatment suitable for most people, and no special effects at present. There is no traditional Chinese medicine treatment for targeted treatment in the existing technology; in view of these defects, it is necessary to design a traditional Chinese medicine medicament for the treatment...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/884A61P11/00A61P31/14A61K33/12A61K35/36
CPCA61K36/07A61K36/076A61K36/884A61K33/12A61K36/718A61K36/71A61K36/65A61K36/736A61K35/36A61K36/484A61P31/14A61P11/00A61K2300/00
Inventor 王相钧王相东王相梅王相静
Owner 王相钧
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap